The Korea Herald

소아쌤

Boryung Pharma to commercialize Aplidin from Spain

By 윤정현

Published : Oct. 4, 2016 - 14:14

    • Link copied

[DISCLOSURE] Boryung Pharmaceutical (003850) reported on Oct. 4 that it has signed a technology introduction contract with PharmaMar of Spain for rights to launch and commercialize Aplidin, a treatment option for multiple myeloma, in Korea.

By Yun Jeong-hyeon (clareyun@heraldcorp.com)